Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 11.94
-0.42 (-3.40%)
At close: Apr 9, 2026
Newland Pharmaceutical Revenue
In the year 2025, Newland Pharmaceutical had annual revenue of 672.38M CNY, down -7.44%. Newland Pharmaceutical had revenue of 191.14M in the quarter ending December 31, 2025, with 1.03% growth.
Revenue
672.38M
Revenue Growth
-7.44%
P/S Ratio
6.96
Revenue / Employee
645.28K
Employees
1,042
Market Cap
4.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 672.38M | -54.06M | -7.44% |
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Starry Pharmaceutical | 2.39B |
| Yabao Pharmaceutical Group | 2.27B |
| Fuan Pharmaceutical (Group) | 1.71B |
| Hunan Fangsheng Pharmaceutical | 1.68B |
| Bide Pharmatech | 1.32B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.17B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |